Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological advancements
3.2.1.2 Rising R&D spending by pharmaceutical industry & government research organizations
3.2.1.3 Increasing adoption of analytical instrumentation for precision medicine applications
3.2.1.4 Growing prevalence of chronic diseases
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of instruments
3.2.2.2 Lack of skilled professionals
3.3 Growth potential analysis
3.4 Pricing analysis, 2024
3.4.1 North America
3.4.2 Europe
3.4.3 Asia Pacific
3.4.4 Latin America
3.4.5 MEA
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Volume analysis, 2021 – 2034 (Units)
3.6.1 Global
3.6.2 North America
3.6.3 Europe
3.6.4 Asia Pacific
3.6.5 Latin America
3.6.6 MEA
3.7 Technology landscape
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Molecular analysis instruments
5.3 Spectroscopy instruments
5.4 Chromatography instruments
5.5 Electrochemical analysis instruments
5.6 Particle counters and analyzers
5.7 Other products
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Spectroscopy
6.3 Chromatography
6.4 Particle analysis
6.5 Polymerase chain reaction
6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Clinical research
7.3 Clinical diagnostics
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical & biotechnology industry
8.3 Research and academic institutes
8.4 Diagnostic centers
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Thailand
9.4.7 Indonesia
9.4.8 Philippines
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Turkey
9.6.6 Iran
Chapter 10 Company Profiles
10.1 Agilent
10.2 Avantor
10.3 BIO-RAD
10.4 BRUKER
10.5 Danaher
10.6 Eppendorf
10.7 HITACHI
10.8 Illumina
10.9 Malvern Panalytical
10.10 Metrohm
10.11 METTLER TOLEDO
10.12 Revvity (PerkinElmer)
10.13 Roche
10.14 Sartorius
10.15 SHIMADZU
10.16 Thermo Fisher Scientific
10.17 Waters
10.18 ZEISS Group
